Literature DB >> 23102123

A new informant-based questionnaire for instrumental activities of daily living in dementia.

Sietske A M Sikkes1, Elly S M de Lange-de Klerk, Yolande A L Pijnenburg, Freek Gillissen, Rolinka Romkes, Dirk L Knol, Bernard M J Uitdehaag, Philip Scheltens.   

Abstract

BACKGROUND: Interference in everyday functioning is part of the diagnostic criteria for dementia. Questionnaires measuring "instrumental activities of daily living" (IADL) are used to measure this interference, but the psychometric quality of these questionnaires is often questioned. In addition, these questionnaires are less suited for early-onset patients. This is problematic, given the high frequency of relatively young patients in memory clinics. In this article, we describe the development and psychometric properties of a new informant-based IADL questionnaire aimed at detecting incipient dementia and appropriate for a broad age range.
METHODS: We defined IADL in consensus with experts and constructed items based on existing items and suggestions from experts and informants. Informants of subjects (n = 206) who visited the Alzheimer Center of the VU University Medical Center completed the questionnaire. Factor structure was investigated using classical exploratory factor analysis and item response theory. We assessed test-retest reliability in 73 informants using weighted κ values.
RESULTS: The questionnaire consisted of 75 items and was computerized to enhance ease of administration. Exploratory factor analysis supported a single-factor model, with 48.3% of the variance being explained by the first factor. We removed five items, as they did not fit the model. High internal consistency was demonstrated. Test-retest reliability showed that the majority of items (87.9%) had substantial-to-almost perfect κ values.
CONCLUSION: The Amsterdam IADL Questionnaire (Amsterdam IADL questionnaire is a registered trademark of Alzheimer Center VU University Medical Center, Amsterdam, The Netherlands) is a 70-item informant-based computerized questionnaire aimed at detecting early dementia and early-onset dementia. Initial results show that this questionnaire is a promising new tool.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23102123     DOI: 10.1016/j.jalz.2011.08.006

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  27 in total

1.  EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.

Authors:  P Aisen; J Touchon; R Amariglio; S Andrieu; R Bateman; J Breitner; M Donohue; B Dunn; R Doody; N Fox; S Gauthier; M Grundman; S Hendrix; C Ho; M Isaac; R Raman; P Rosenberg; R Schindler; L Schneider; R Sperling; P Tariot; K Welsh-Bohmer; M Weiner; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2017

Review 2.  Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients.

Authors:  Terri S Armstrong; Mark R Gilbert
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 3.  Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.

Authors:  Linda Dirven; Jacob C Reijneveld; Neil K Aaronson; Andrew Bottomley; Bernard M J Uitdehaag; Martin J B Taphoorn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

4.  Ecological Assessment of Autonomy in Instrumental Activities of Daily Living in Dementia Patients by the Means of an Automatic Video Monitoring System.

Authors:  Alexandra König; Carlos Fernando Crispim-Junior; Alvaro Gomez Uria Covella; Francois Bremond; Alexandre Derreumaux; Gregory Bensadoun; Renaud David; Frans Verhey; Pauline Aalten; Philippe Robert
Journal:  Front Aging Neurosci       Date:  2015-06-02       Impact factor: 5.750

Review 5.  Amsterdam Dementia Cohort: Performing Research to Optimize Care.

Authors:  Wiesje M van der Flier; Philip Scheltens
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire.

Authors:  Roos J Jutten; Carel F W Peeters; Sophie M J Leijdesdorff; Pieter Jelle Visser; Andrea B Maier; Caroline B Terwee; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (Amst)       Date:  2017-03-31

7.  Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.

Authors:  Q Oort; L Dirven; W Meijer; S A M Sikkes; B M J Uitdehaag; J C Reijneveld; M J B Taphoorn
Journal:  J Neurooncol       Date:  2017-02-01       Impact factor: 4.130

8.  A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test-retest reliability and feasibility.

Authors:  Roos J Jutten; John Harrison; Philippe R Lee Meeuw Kjoe; Esther M Opmeer; Niki S M Schoonenboom; Frank Jan de Jong; Craig W Ritchie; Philip Scheltens; Sietske A M Sikkes
Journal:  Alzheimers Dement (Amst)       Date:  2017-12-27

Review 9.  Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Authors:  Sandra Weintraub; Maria C Carrillo; Sarah Tomaszewski Farias; Terry E Goldberg; James A Hendrix; Judith Jaeger; David S Knopman; Jessica B Langbaum; Denise C Park; Michael T Ropacki; Sietske A M Sikkes; Kathleen A Welsh-Bohmer; Lisa J Bain; Robert Brashear; Kumar Budur; Ana Graf; Ferenc Martenyi; Marta Segardahl Storck; Christopher Randolph
Journal:  Alzheimers Dement (N Y)       Date:  2018-02-13

10.  The Missing Link in the Pathophysiology of Vascular Cognitive Impairment: Design of the Heart-Brain Study.

Authors:  Astrid M Hooghiemstra; Anne Suzanne Bertens; Anna E Leeuwis; Esther E Bron; Michiel L Bots; Hans-Peter Brunner-La Rocca; Anton J M de Craen; Rob J van der Geest; Jacoba P Greving; L Jaap Kappelle; Wiro J Niessen; Robert J van Oostenbrugge; Matthias J P van Osch; Albert de Roos; Albert C van Rossum; Geert Jan Biessels; Mark A van Buchem; Mat J A P Daemen; Wiesje M van der Flier
Journal:  Cerebrovasc Dis Extra       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.